Cybin Inc
Cybin Inc., a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anx… Read more
Cybin Inc (CYBN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.248x
Based on the latest financial reports, Cybin Inc (CYBN) has a cash flow conversion efficiency ratio of -0.248x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-34.48 Million) by net assets ($139.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cybin Inc - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Cybin Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cybin Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cybin Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ho Tung Chemical Corp
TW:1714
|
-0.013x |
|
ANY Security Printing PLC
BUD:ANY
|
0.406x |
|
Eugene Inv&Sec
KO:001200
|
0.184x |
|
The RMR Group Inc
F:26R
|
0.026x |
|
Net Lease Office Properties
NYSE:NLOP
|
0.038x |
|
Raymond Lifestyle Ltd
NSE:RAYMONDLSL
|
N/A |
|
Warpaint London PLC
OTCQX:WPNTF
|
0.147x |
|
Zhejiang Zomax Transmission
SHG:603767
|
0.010x |
Annual Cash Flow Conversion Efficiency for Cybin Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of Cybin Inc from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $237.20 Million | $-101.30 Million | -0.427x | -80.93% |
| 2024-03-31 | $291.93 Million | $-68.91 Million | -0.236x | +60.24% |
| 2023-03-31 | $76.16 Million | $-45.21 Million | -0.594x | -168.68% |
| 2022-03-31 | $86.12 Million | $-19.03 Million | -0.221x | +98.32% |
| 2021-03-31 | $1.45 Million | $-19.03 Million | -13.140x | -1373889.02% |
| 2020-03-31 | $1.45 Million | $-1.38K | -0.001x | +99.55% |
| 2019-03-31 | $394.73K | $-83.78K | -0.212x | +60.57% |
| 2018-03-31 | $440.25K | $-237.03K | -0.538x | -5701.70% |
| 2017-03-31 | $292.78K | $2.81K | 0.010x | -- |